Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRQIH.L Regulatory News (RQIH)

  • There is currently no data for RQIH

Response to requisition

12 Aug 2022 18:20

RNS Number : 9301V
R&Q Insurance Holdings Ltd
12 August 2022
 

FOR IMMEDIATE RELEASE

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

12 August 2022

 

R&Q Insurance Holdings Ltd ("R&Q" or the "Company")

Response to requisition by Phoenix Asset Management Partners Limited ("Phoenix")

 

The Board of R&Q (the "Board") notes that it has received a requisition notice effective 12 August 2022 from Phoenix (holding 12.2% of the Company's issued share capital) to requisition a special general meeting of the Company to be held for the purpose of tabling resolutions to remove William Spiegel, our Executive Chairman, as a Director of the Company and to appoint Ken Randall as a Director of the Company and, if William Spiegel is removed, to act as an executive director to fill the vacancy created by William's removal.

The Board has sought to engage constructively with Phoenix to understand the motivations for their proposals and appropriately address any potential concerns. However, during these discussions, Phoenix have, in the Board's view, failed to articulate any sound justification for such proposals being in the best interests of the Company.

The Board is focused on delivering shareholder value and is unanimous in its support for William Spiegel and the strategy he and his executive team have set out for the Company. This support was endorsed at the recent AGM (held on 14 July 2022) where the Company's shareholders (excluding Phoenix and Ken Randall) voted 84.5% in favour of the reappointment of William Spiegel as Executive Chairman.

The Board is respectful of Ken Randall as a founder of the business; however, the Board considers that these proposals by Phoenix would run counter to the wishes of shareholders as a whole (as shown at the recent AGM vote), the independent governance procedures for the appointment of all Board Directors, the broader independence of the Board and the improvements in reporting, transparency, governance, finance, capital, operations and risk management that have been undertaken since William's appointment in April 2021 and as set out in further detail in the Company's 2021 Annual Report.

Therefore, having carefully considered these proposals in consultation with its advisors, the Board has unanimously concluded that they would not be in the best interests of the Company's shareholders as a whole, and recommends that shareholders vote against these proposals if put to shareholders at a special general meeting.

Following an extensive review in the second half of 2021, the Board had intended to take certain actions in line with corporate governance best practice including the appointment of a new Independent Non-Executive Chairman and an additional Independent Non-Executive Director. This process was delayed initially by the Brickell offer and more recently by the discussions we have had with Phoenix in relation to these proposals. The Board will now proceed with these arrangements as soon as possible.

In addition to its support for the strategy William and his team have set out, which the Board considers to be the right plan being executed by the right team with the right experience, the Board also wishes to reiterate the significant actions taken to improve operational and cultural issues at the Company.

R&Q maintains a regular dialogue with all of its shareholders, and will continue to engage with Phoenix constructively in relation to their views.

A further announcement will be made in due course.

The person responsible for making this announcement on behalf of R&Q is David Gormley, Group Company Secretary.

 

Enquiries to:

 

R&Q Insurance Holdings Ltd Tel: +44(0)20 7780 5850

William Spiegel

Tom Solomon

 

Numis Securities Limited (Nominated Adviser and Joint Broker) Tel : +44 (0)20 7260 1000

Charles Farquhar

Giles Rolls

 

Barclays Bank PLC (Joint Broker) Tel: +44 (0)20 7632 2322

Nish Amin

Chris Madderson

 

FTI Consulting Tel: +44 (0)20 3727 1051

Tom Blackwell

 

 

 

 

 

 

Notes to Editors:

 

About R&Q 

 

R&Q is a non-life global specialty insurance company operating two highly complementary, businesses: Program Management and Legacy Insurance. Both of these businesses are leaders in markets with high barriers to entry and significant growth opportunities. Legacy Insurance generates profits and capital extractions from expert management of legacy non-life insurance portfolios. Program Management generates commission income from its licensed (and rated) carriers in the US, EU and the UK, writing niche and profitable program business, largely on behalf of highly rated reinsurers.

 

Legal Entity Identifier (LEI): 2138006K1U38QCGLFC94

 

Website: www.rqih.com

 

Important Notices

 

 

Numis Securities Limited ("Numis"), which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively for R&Q and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters in this announcement and will not be responsible to anyone other than R&Q for providing the protections afforded to clients of Numis, nor for providing advice in relation to any matter referred to herein.

Barclays Bank PLC ("Barclays") is authorised by the Prudential Regulation Authority (the "PRA") and regulated in the United Kingdom by the PRA and the FCA. Barclays is acting exclusively for the Company and no one else in connection with the content of this announcement or any matters described in this announcement. Barclays will not regard any other person as its client in relation to the content of this announcement or any matters described in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice to any other person in relation to any matter referred to herein.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RSPFLFLDTAIFLIF
Date   Source Headline
29th Jul 20247:00 amRNSCancellation - R&Q INSURANCE HOLDINGS LTD
28th Jun 20246:07 pmRNSSale of Accredited to Onex Partners
27th Jun 20247:00 amRNSAppointment of Joint Provisional Liquidators
24th Jun 20247:00 amRNSUpdate
24th Jun 20247:00 amRNSR&Q agrees sale of Inceptum
20th Jun 20244:59 pmRNSTR-1: Notification of major holdings
20th Jun 20241:12 pmRNSTR-1: Notification of major holdings
19th Jun 20242:46 pmRNSTR-1: Notification of major holdings
19th Jun 20242:26 pmRNSTR-1: Notification of major holdings
19th Jun 20247:30 amRNSSuspension - R&Q Insurance Holdings Ltd
19th Jun 20247:00 amRNSUpdate
18th Jun 20242:19 pmRNSNotification of major holdings
17th Jun 20241:29 pmRNSTR-1: Notification of major holdings
14th Jun 20243:16 pmRNSTR-1: Notification of major holdings
13th Jun 20247:35 amRNSUpdate on proposed sale of Accredited
24th Apr 20245:40 pmRNSUpdate on proposed sale of Accredited
19th Apr 20247:00 amRNSAppointment of Non-Executive Directors
12th Apr 20247:00 amRNSUpdate on Trading and Sale of Accredited
12th Mar 20242:33 pmRNSTR-1: Notification of major holdings
1st Mar 20247:00 amRNSComment on recent press speculation
11th Jan 20244:01 pmRNSShareholders approve sale of Accredited
4th Jan 20244:27 pmRNSIncrease in the number of Treasury Shares
2nd Jan 20247:00 amRNSRetirement of Alan Quilter
22nd Dec 20237:00 amRNSUpdate on discussions with the BMA
21st Dec 202311:12 amRNSTR-1: Notification of major holdings
14th Dec 20237:00 amRNSPosting of Circular
16th Nov 20239:58 amRNSTR-1: Notification of major holdings
14th Nov 20237:00 amRNSUpdate on Proposed Sale of Accredited
27th Oct 20234:52 pmRNSPDMR/Director Shareholding and Total Voting Rights
26th Oct 20237:00 amRNSLoss Portfolio Transfer
26th Oct 20237:00 amRNSChange of External Auditor
20th Oct 20235:23 pmRNSProposed Sale of R&Q’s Program Management business
16th Oct 202310:59 amRNSTR-1: Notification of major holdings
29th Sep 20237:00 amRNSResults for the half year ended 30 June 2023
22nd Sep 20237:00 amRNSStatement re Press Comment
20th Sep 202311:55 amRNSTR-1: Notification of major holdings
20th Sep 202311:54 amRNSTR-1: Notification of major holdings
16th Aug 20233:36 pmRNSPDMR/Director Shareholding and Total Voting Rights
28th Jul 20233:18 pmRNSResult of Annual General Meeting
18th Jul 20233:22 pmRNSTR-1: Notification of major holdings
17th Jul 20237:00 amRNSAppointment of Non-Executive Director
30th Jun 202310:08 amRNSAppointment of Non-Executive Director
30th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
29th Jun 20237:00 amRNSResults for the year ended 31 December 2022
26th Jun 20237:00 amRNSAccredited receives independent AM Best Rating
12th Jun 20237:00 amRNSR&Q raises up to $60 million of new equity
6th Jun 20235:31 pmRNSTR-1: Notification of major holdings
5th Jun 202311:23 amRNSTR-1: Notification of major holdings
2nd Jun 20233:50 pmRNSTR-1: Notification of major holdings
16th May 20239:27 amRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.